Capha Pharmaceuticals Inc. Stock Other OTC
Equities
FPSUF
CA13962W1086
Pharmaceuticals
Sales 2021 | - | Sales 2022 | - | Capitalization | 8.87K 12.08K |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net Debt 2021 | 335K 456K | Net Debt 2022 | 415K 565K | EV / Sales 2022 | - |
P/E ratio 2021 |
-0.15
x | P/E ratio 2022 |
-0.12
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 33.36% |
Managers | Title | Age | Since |
---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 02-10-30 |
Janice Brown
BRD | Director/Board Member | - | 02-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 02-10-30 |
Janice Brown
BRD | Director/Board Member | - | 02-10-31 |
1st Jan change | Capi. | |
---|---|---|
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |